The group’s principal activities include discovering and developing medicines. The services of the group include neurology, reproductive health and metabolic endocrinology. The group products sold under the trade names Novantrone(R), Rebif(R), Gonal-f(R), Ovidrel(R) and Cetrotide(R). The group operates from the United States.
Executive Information
Name
Title
Email
Fereydoun Firouz
Pres. - EMD Serono, Inc
N/A
Paul Lammers
Chief Medical Officer
N/A
Steve Arkinstall
Head - Research, EMD Serono Research Institute, Inc
